Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats
Naimesh Solanki, Tomilowo Abijo, Carine Galvao, et al.
Behavioural Brain Research (2020) Vol. 385, pp. 112563-112563
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
Blum Kenneth, Modestino J Edward, Gondre Lewis C Marjorie, et al.
PubMed (2018) Vol. 1, Iss. 2
Closed Access | Times Cited: 71
GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential
Ravinder Naik Dharavath, Celeste Pina‐Leblanc, Victor M. Tang, et al.
Frontiers in Neural Circuits (2023) Vol. 17
Open Access | Times Cited: 18
Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
Mark S. Gold, David Baron, Abdalla Bowirrat, et al.
Journal of the Neurological Sciences (2020) Vol. 418, pp. 117137-117137
Open Access | Times Cited: 45
Pre-clinical models of reward deficiency syndrome: A behavioral octopus
Marjorie C. Gondré‐Lewis, Rosemary B. Bassey, Kenneth Blum
Neuroscience & Biobehavioral Reviews (2020) Vol. 115, pp. 164-188
Open Access | Times Cited: 37
A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J. Modestino, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 212-212
Open Access | Times Cited: 24
Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters
Benjamin M. Williams, Nathan D. Steed, Joel T. Woolley, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1738-1754
Open Access | Times Cited: 3
Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch
Kenneth Blum, Jean Lud Cadet, Mark S. Gold
Journal of the Neurological Sciences (2020) Vol. 420, pp. 117252-117252
Open Access | Times Cited: 26
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions
Kenneth Blum, Abdalla Bowirrat, Eric R. Braverman, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 21, pp. 11529-11529
Open Access | Times Cited: 22
Non-invasive neuromodulation of dorsolateral prefrontal cortex to reduce craving in alcohol use disorder: A meta-analysis
Maryam Sorkhou, Nicolette Stogios, Negar Sayrafizadeh, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 4, pp. 100076-100076
Open Access | Times Cited: 14
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
Mark S. Gold, Kenneth Blum, Abdalla Bowirrat, et al.
INNOSC Theranostics and Pharmacological Sciences (2024) Vol. 7, Iss. 3, pp. 1918-1918
Closed Access | Times Cited: 2
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”
Kenneth Blum, Bruce Steinberg, Marjorie C. Gondré‐Lewis, et al.
Psychology Research and Behavior Management (2021) Vol. Volume 14, pp. 2115-2134
Open Access | Times Cited: 17
Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation
Kenneth Blum, Mark S. Brodie, Subhash C. Pandey, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 1009-1009
Open Access | Times Cited: 12
Why haven't we solved the addiction crisis?
Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, et al.
Journal of the Neurological Sciences (2022) Vol. 442, pp. 120404-120404
Closed Access | Times Cited: 11
Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression
Kenneth Blum, Mark S. Gold, Jean Lud Cadet, et al.
Current Psychopharmacologye (2021) Vol. 11, Iss. 1, pp. 11-17
Open Access | Times Cited: 14
Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration
B. William Downs, Kenneth Blum, Debasis Bagchi, et al.
Journal of Systems and Integrative Neuroscience (2020) Vol. 6, Iss. 3
Open Access | Times Cited: 13
Epigenetic Effects of Psychoactive Drugs
Rania Ahmed, Kenneth Blum, Panayotis K. Thanos
Current Pharmaceutical Design (2023) Vol. 29, Iss. 27, pp. 2124-2139
Closed Access | Times Cited: 4
DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of “Dopamine Homeostasis” in the Face of the Opioid Crisis
Anish Bajaj, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1416-1416
Open Access | Times Cited: 6
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, et al.
PubMed (2021) Vol. 4, Iss. 2, pp. 17-24
Closed Access | Times Cited: 8
Hui Medicine Moxibustion Promotes the Absorption of Lumbar Disc Herniation and the Recovery of Motor Function in Rats through Fas/FasL Signaling Pathway
Jianfeng Xu, Qiang Luo, Junyao Song, et al.
BioMed Research International (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 5
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 2015-2015
Open Access | Times Cited: 5
Invited Expert Opinion- Bio-informatic and Limitation Di-rectives to Help Adopt Ge-netic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Re-quired Analytic Evidence to Induce Dopamine Homeo-statsis
Kenneth Blum, Mark S. Gold, Jean Lud Cadet, et al.
Medical Research Archives (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 2
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs.
Edward J. Modestino, Abdalla Bowirrat, David Baron, et al.
PubMed (2024) Vol. 8, Iss. 1, pp. 34-49
Closed Access
Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
B. William Downs, Steve Kushner, Manashi Bagchi, et al.
Current Psychopharmacologye (2021) Vol. 10, Iss. 2, pp. 123-137
Closed Access | Times Cited: 2
Assessing Collegiate Recovery Programs and the Challenges of Campus Binge Drinking
Andrew Downing, Jessica Hulsey
Current Psychopharmacologye (2020) Vol. 10, Iss. 1, pp. 24-33
Closed Access | Times Cited: 1
Neurogenetics of alcohol use disorder a subset of reward deficiency syndrome: candidate genes to be or not to be?
Kenneth Blum, Jean Lud Cadet, Panayotis K. Thanos, et al.
Elsevier eBooks (2022), pp. 105-160
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top